Shanghai Chuangnuo Pharmaceutical Co., Ltd. was established in 2005 as a member company of Chuangnuo Pharmaceutical Group, focusing on the research, development, production, and sales of anti-cancer drug raw materials and formulations. It is one of the earliest suppliers of paclitaxel and docetaxel raw materials in China. Driven by research and innovation, Chuangnuo Pharmaceutical owns the Shanghai Anti-cancer Drug Engineering Technology Center and an anti-cancer drug industrialization platform; it is dedicated to small-molecule anti-cancer drug formulations and their supporting small-scale specialty raw materials, with complete and independent cytotoxic and non-cytotoxic production lines.
Shanghai Chuangnuo Pharmaceutical Group was founded in 1996, originally named Desano, and renamed Chuangnuo Pharmaceutical Group in 2012. The company's management headquarters is located in Shanghai Zhangjiang Hi-Tech Park, with production bases in Shanghai, Jiangsu, Jiangxi, and Inner Mongolia, employing over 5,000 people. After more than 20 years of development, it has formed an anti-cancer drug business centered on the Chuangnuo brand, an anti-AIDS drug business centered on the Desano brand, and a vitamin and nutrition business centered on the Haijianuo brand. The group ranks among the top 100 pharmaceutical industrial enterprises in China, with annual sales exceeding 5 billion yuan, and its business spans more than 70 countries and regions worldwide, making it a well-known domestic pharmaceutical group enterprise integrating raw materials and formulations.
Chuangnuo Pharmaceutical Group is investing in the construction of a new raw material production base in Xingan, Jiangxi, and a solid dosage form plant in Zhangshu, Jiangxi. The Xingan base covers an area of approximately 460 mu, focusing on the production of pharmaceutical raw materials, intermediates, and vitamins, with a total investment of 2 billion yuan, expected to achieve annual sales revenue of 5 billion yuan from raw materials and intermediates. The Zhangshu plant, dominated by anti-cancer solid dosage forms, is equipped with cytotoxic and non-cytotoxic production lines, with a designed capacity of 2 billion tablets (capsules) per year. We are currently building a young and professional technical and management team, and sincerely invite you to join us to work together for a bright future.
Shanghai Chuangnuo Pharmaceutical Group has always adhered to the mission of "Caring for life, working hard for human health," pursuing cooperation, innovation, and corporate responsibility, and is committed to building an international, sustainable enterprise with special competitive advantages and brand influence.
What does Shanghai Chuangnuo Pharmaceutical Co., Ltd. require? Who is Chuangnuo Pharmaceutical hiring? Chuangnuo Pharmaceutical recruitment: 医疗卫生/美容保健类占比最多占29.5%，其次是经营管理类占28.2%. What education can get in at Chuangnuo Pharmaceutical? 本科占比最多占62.8%，其次是大专占28.2%. High education required at Chuangnuo Pharmaceutical? 硕士占5.1%. Work experience required at Chuangnuo Pharmaceutical? 5-10年占比最多占43.6%，其次是3-5年占30.8%. Where are the job locations at Chuangnuo Pharmaceutical? 上海占比最多占60.3%，其次是南通占14.1%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
